Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer

BACKGROUND: This retrospective analysis was planned as a direct comparison of taxanes plus trastuzumab to the less toxic combination of oral vinorelbine (OV) plus trastuzumab as a first-line therapy for metastatic HER2-positive breast cancer. PATIENTS AND METHODS: Patients (n = 76) receiving either...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Care (Basel)
Main Authors: Bergen, Elisabeth, Berghoff, Anna S., Rudas, Margaretha, Dubsky, Peter, De Vries, Catharina, Sattlberger, Claudia, Mader, Robert M., Zagouri, Flora, Sparber, Cornelia, Fitzal, Florian, Gnant, Michael, Rottenfusser, Andrea, Zielinski, Christoph C., Preusser, Matthias, Steger, Guenther G., Bartsch, Rupert
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger GmbH 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4322687/
https://ncbi.nlm.nih.gov/pubmed/25759615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368330
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados